Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs

Avcu G., Sensoy G., Celiksoy M. H., Sogut A., Kefeli M., Karli A., ...More

PEDIATRICS INTERNATIONAL, vol.57, no.1, pp.155-157, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 57 Issue: 1
  • Publication Date: 2015
  • Doi Number: 10.1111/ped.12403
  • Journal Name: PEDIATRICS INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.155-157
  • Keywords: anti-tuberculosis drug, ethambutol, leukocytoclastic vasculitis, rifampicin, RIFAMPIN
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Leukocytoclastic vasculitis (LCV), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti-tuberculosis drugs is very rarely seen. This report describes the case of a 12-year-old girl who developed LCV with rifampicin and ethambutol while undergoing anti-tuberculosis treatment due to extensive pulmonary involvement.